Invention Grant
US09241924B2 Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
有权
5-乙基-2- {4- [4-（4-四唑-1-基 - 苯氧基甲基） - 噻唑-2-基] - 哌啶-1-基} - 嘧啶的组合物
![Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine](/docs/US/2016-01-26/US09241924B2/abs.jpg.600x600.jpg)
- Patent Title: Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
- Patent Title (中): 5-乙基-2- {4- [4-（4-四唑-1-基 - 苯氧基甲基） - 噻唑-2-基] - 哌啶-1-基} - 嘧啶的组合物
-
Application No.: US13165651Application Date: 2011-06-21
-
Publication No.: US09241924B2Publication Date: 2016-01-26
- Inventor: Charles A. McWherter , Robert Louis Martin , David B. Karpf , Brian K. Roberts , Douglas Alan Lorenz , Rodney James Ketner
- Applicant: Charles A. McWherter , Robert Louis Martin , David B. Karpf , Brian K. Roberts , Douglas Alan Lorenz , Rodney James Ketner
- Applicant Address: US CA Hayward
- Assignee: CYMABAY THERAPEUTICS, INC.
- Current Assignee: CYMABAY THERAPEUTICS, INC.
- Current Assignee Address: US CA Hayward
- Agency: Foley & Lardner LLP
- Main IPC: A61K31/506
- IPC: A61K31/506 ; A61P3/08 ; A61P3/10 ; A61P3/00 ; A61K9/10 ; C07D417/14 ; A61K31/397 ; A61K9/16 ; A61K9/20
![Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine](/abs-image/US/2016/01/26/US09241924B2/abs.jpg.150x150.jpg)
Abstract:
This invention relates to the field of pharmaceutical chemistry and, more specifically, to pharmaceutical formulations as well as to intermediates used to prepare such formulations and to methods for manufacturing such formulations.
Public/Granted literature
- US20110318418A1 COMPOSITIONS OF 5-ETHYL-2--PYRIMIDINE Public/Granted day:2011-12-29
Information query
IPC分类:
